Alaunos Therapeutics (TCRT) News Today $2.16 +0.03 (+1.41%) (As of 10:14 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Precigen Terminates License Agreement With Alaunos TherapeuticsOctober 11, 2024 | marketwatch.comAlaunos Therapeutics Ends Licensing Deal, Reassesses StrategyOctober 11, 2024 | finance.yahoo.comAlaunos Therapeutics (NASDAQ:TCRT) Stock, Short Interest ReportSeptember 26, 2024 | benzinga.comAlaunos Therapeutics (NASDAQ:TCRT) Stock Quotes, Forecast and News SummarySeptember 26, 2024 | benzinga.comStella Pharma Corporation (4888.T) Stock Price, News, Quote & History - Yahoo FinanceSeptember 24, 2024 | finance.yahoo.comTCRT Stock Earnings: Alaunos Therapeutics Reported Results for Q1 2024May 16, 2024 | investorplace.comRevolution Medicines: An Expensive Shot At A Massive Market OpportunityApril 12, 2024 | seekingalpha.comTCRT Stock Earnings: Alaunos Therapeutics Misses EPS for Q4 2023April 8, 2024 | investorplace.comBiora Therapeutics announces $6M registered direct offering and concurrent private placementApril 1, 2024 | msn.comAlaunos Therapeutics (NASDAQ:TCRT) Trading 9% Higher Alaunos Therapeutics (NASDAQ:TCRT) Stock Price Up 9%February 2, 2024 | marketbeat.comTrading was temporarily halted for "TCRT" at 07:01 PM with a stated reason of "News pending."February 1, 2024 | marketbeat.comAlaunos Therapeutics Announces 1-for-15 Reverse Stock SplitJanuary 31, 2024 | msn.comWerewolf Therapeutics Inc (HOWL)January 31, 2024 | investing.comAlaunos Therapeutics Stock (NASDAQ:TCRT) Dividends: History, Yield and DatesDecember 28, 2023 | benzinga.comRecap: Alaunos Therapeutics Q3 EarningsNovember 14, 2023 | benzinga.comWhy Is Alaunos Therapeutics (TCRT) Stock Up 14% Today?November 14, 2023 | investorplace.comAlaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic AlternativesNovember 14, 2023 | finance.yahoo.comAlaunos Therapeutics Inc TCRTNovember 1, 2023 | morningstar.comWhy Is Alaunos Therapeutics Sinking Today?August 15, 2023 | msn.comAlaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic AlternativesAugust 14, 2023 | finance.yahoo.comTrading was temporarily halted for "TCRT" at 04:08 PM with a stated reason of "News pending."August 14, 2023 | marketbeat.comAlaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic MalignanciesJune 29, 2023 | finance.yahoo.comAlaunos Therapeutics Stock (NASDAQ:TCRT), Insider Trading ActivityJune 9, 2023 | benzinga.comAlaunos slips 17% on Phase 1/2 data for cancer cell therapyMay 26, 2023 | msn.comAlaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual MeetingMay 25, 2023 | finance.yahoo.comOne Alaunos Therapeutics Insider Raised Stake By 117% In Previous YearMay 17, 2023 | uk.news.yahoo.comAlaunos Therapeutics upgraded to buy at Wainwright on multiple catalystsMay 15, 2023 | seekingalpha.comAlaunos Therapeutics, Inc. (NASDAQ:TCRT) Q1 2023 Earnings Call TranscriptMay 13, 2023 | finance.yahoo.com8-K: Alaunos Therapeutics, Inc.May 11, 2023 | marketwatch.comAlaunos Therapeutics, Inc.: Alaunos Therapeutics Reports First Quarter 2023 Financial ResultsMay 10, 2023 | finanznachrichten.deAlaunos Therapeutics GAAP EPS of -$0.04 in-lineMay 10, 2023 | msn.comRecap: Alaunos Therapeutics Q1 EarningsMay 10, 2023 | msn.comAlaunos Therapeutics Reports First Quarter 2023 Financial ResultsMay 10, 2023 | finance.yahoo.comAlaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023May 3, 2023 | finance.yahoo.comAlaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual MeetingApril 26, 2023 | finance.yahoo.comThe past five years for Alaunos Therapeutics (NASDAQ:TCRT) investors has not been profitableApril 25, 2023 | finance.yahoo.comAlaunos Therapeutics Inc.April 2, 2023 | barrons.comAlaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of DirectorsMarch 30, 2023 | finance.yahoo.comAlaunos Therapeutics to Participate in Upcoming Investor Conferences in AprilMarch 29, 2023 | finance.yahoo.comAlaunos Therapeutics, Inc. (NASDAQ:TCRT) to Post FY2023 Earnings of ($0.17) Per Share, Cantor Fitzgerald ForecastsAlaunos Therapeutics, Inc. (NASDAQ:TCRT - Get Rating) - Analysts at Cantor Fitzgerald dropped their FY2023 earnings estimates for Alaunos Therapeutics in a report released on Wednesday, March 8th. Cantor Fitzgerald analyst P. Agrawal now anticipates that the company will earn ($0.17) per share foMarch 13, 2023 | marketbeat.comWhen Will Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Turn A Profit?March 10, 2023 | finance.yahoo.comQ1 2023 EPS Estimates for Alaunos Therapeutics, Inc. Increased by HC Wainwright (NASDAQ:TCRT)Alaunos Therapeutics, Inc. (NASDAQ:TCRT - Get Rating) - Equities research analysts at HC Wainwright boosted their Q1 2023 EPS estimates for Alaunos Therapeutics in a research report issued to clients and investors on Wednesday, March 8th. HC Wainwright analyst S. Ramakanth now forecasts that theMarch 10, 2023 | marketbeat.comAlaunos Therapeutics's Return On Capital Employed OverviewMarch 9, 2023 | msn.comAlaunos Therapeutics, Inc. (NASDAQ:TCRT) Q4 2022 Earnings Call TranscriptMarch 9, 2023 | finance.yahoo.comEarnings Outlook For Alaunos TherapeuticsMarch 6, 2023 | msn.comAlaunos (TCRT) to Report Q4 Earnings: What's in the Cards?March 3, 2023 | msn.comAlaunos Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023March 1, 2023 | finance.yahoo.comErgoteles LLC Has $835,000 Holdings in Alaunos Therapeutics, Inc. (NASDAQ:TCRT)Ergoteles LLC trimmed its position in Alaunos Therapeutics, Inc. (NASDAQ:TCRT - Get Rating) by 48.2% in the third quarter, according to its most recent filing with the SEC. The fund owned 485,434 shares of the company's stock after selling 451,466 shares during the period. Ergoteles LLC owned 0.22%February 28, 2023 | marketbeat.comAlaunos Therapeutics, Inc.'s (NASDAQ:TCRT) largest shareholders are individual investors with 58% ownership, institutions own 22%February 17, 2023 | finance.yahoo.comIs Alaunos Therapeutics (TCRT) Outperforming Other Medical Stocks This Year?January 24, 2023 | finance.yahoo.com Get Alaunos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TCRT and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide TCRT Media Mentions By Week TCRT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TCRT News Sentiment▼0.000.47▲Average Medical News Sentiment TCRT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TCRT Articles This Week▼00▲TCRT Articles Average Week Get Alaunos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TCRT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sol-Gel Technologies News Bright Green News AIM ImmunoTech News NLS Pharmaceutics News Talphera News NKGen Biotech News Sensei Biotherapeutics News Conduit Pharmaceuticals News Aspira Women's Health News ImmunoPrecise Antibodies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TCRT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alaunos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
